Atlas Trials

Hepatocellular Carcinoma Recurrent

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hepatocellular Carcinoma Recurrent

RecordFirmDate
Bevacizumab Biosimilar Plus FOLFOX4 in the Treatment of Recurrent HCC After Liver Transplantation (NCT05355155)The First Affiliated Hospital with Nanjing Medical University2022-05-01
Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis (NCT05990959)China Medical University Hospital2022-04-22
Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study) (NCT05277675)Southwest Hospital, China2021-11-01
Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence (NCT04506398)RenJi Hospital2020-09-10
Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant (NCT04425226)RenJi Hospital2020-08-06
A RCT of TNF and ENT in the Treatment of Long-term Prognosis With Hepatitis B-related HCC After Curative Resection (NCT04392700)Sun Yat-sen University2019-07-25
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC (NCT03313648)Southwest Hospital, China2016-09-01
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma (NCT02423343)Eli Lilly and Company2015-01-01
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01009593)Abbott2010-01-01
Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant (NCT06233708)Asan Medical Center2008-01-01

Track Hepatocellular Carcinoma Recurrent automatically

Every clearance here is in the API, with alerts when new ones post.